Clinical Safety of Extended Interval Dosing of Nivolumab in Patients with Melanoma.

Saved in:
Bibliographic Details
Title: Clinical Safety of Extended Interval Dosing of Nivolumab in Patients with Melanoma.
Authors: Malmberg R; Department of Hospital Pharmacy, Erasmus University Medical Centre, Rotterdam, The Netherlands.; Department of Medical Oncology, Erasmus University Medical Centre, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Hofman MM; Department of Medical Oncology, Erasmus University Medical Centre, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Pulmonary Medicine, Erasmus University Medical Centre, Rotterdam, The Netherlands., Ashad F; Department of Hospital Pharmacy, Erasmus University Medical Centre, Rotterdam, The Netherlands., Daloul A; Department of Hospital Pharmacy, Erasmus University Medical Centre, Rotterdam, The Netherlands., Oosterveld S; Department of Hospital Pharmacy, Erasmus University Medical Centre, Rotterdam, The Netherlands., Basak EA; Department of Medical Oncology, Erasmus University Medical Centre, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Oomen-de Hoop E; Department of Medical Oncology, Erasmus University Medical Centre, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van der Veldt AAM; Department of Medical Oncology, Erasmus University Medical Centre, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Radiology and Nuclear Medicine, Erasmus University Medical Centre, Rotterdam, The Netherlands., Joosse A; Department of Medical Oncology, Erasmus University Medical Centre, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van Leeuwen RWF; Department of Hospital Pharmacy, Erasmus University Medical Centre, Rotterdam, The Netherlands.; Department of Medical Oncology, Erasmus University Medical Centre, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus University Medical Centre, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2026 Apr; Vol. 119 (4), pp. 997-1004. Date of Electronic Publication: 2025 Dec 25.
Publication Type: Journal Article
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1532-6535
DOI:10.1002/cpt.70182